SynthesisCancer research and treatment2024

Precision Oncology Clinical Trials: A Systematic Review of Phase II Clinical Trials with Biomarker-Driven, Adaptive Design.

Hyerim Ha et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.